Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 558 across all filing types
Latest filing 2023-07-31 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688315

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
北京诺禾致源科技股份有限公司第三届监事会第八次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Beijing Nuohe Zhiyuan Technology Co., Ltd. It discusses the approval of the company's 2023 semi-annual report and related matters, including the use of raised funds and foreign exchange hedging business. The document references the 2023 semi-annual report and other announcements published on the Shanghai Stock Exchange website but does not contain the actual financial statements or detailed report content itself. The document length is short (1636 characters) and serves as an official announcement of meeting resolutions and approvals rather than the report itself. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution notice rather than an Interim/Quarterly Report (IR) or Annual Report (10-K).
2023-07-31 Chinese
北京诺禾致源科技股份有限公司关于召开2023年半年度业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling and details of a half-year performance explanation meeting (业绩说明会) for the company's 2023 half-year results. It mentions that the company's 2023 half-year report has already been published on August 1, 2023, and this meeting is to discuss and explain that report to investors. The document does not contain actual financial statements or substantive financial data but rather provides logistical information about the upcoming investor presentation and Q&A session. The document length is short (1455 characters), and it serves as a notice for an event related to the interim report rather than the report itself. Therefore, it fits best under the category of Investor Presentation (IP), as it is a detailed presentation event focusing on financials and strategy for investors.
2023-07-31 Chinese
北京诺禾致源科技股份有限公司2023年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2023 年半年度报告" which translates to "2023 Semi-Annual Report." It contains detailed financial data, management discussion and analysis, company overview, business operations, and financial indicators for the period January 1, 2023 to June 30, 2023. The document is lengthy (15,000 characters) and includes comprehensive financial statements and analysis, not just an announcement or summary. The presence of management discussion and analysis, financial data, and detailed operational information confirms it is a substantive interim financial report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2023-07-31 Chinese
北京诺禾致源科技股份有限公司关于开展外汇套期保值业务的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Beijing Novogene Technology Co., Ltd. regarding the commencement of foreign exchange hedging business. It details the purpose, amount, funding source, transaction methods, risk analysis, risk control measures, accounting treatment, and approval procedures related to the foreign exchange hedging activities. The document includes opinions from independent directors, the supervisory board, and the sponsoring institution. It is a formal disclosure about a specific financing-related activity (foreign exchange hedging) and does not contain financial statements or quarterly/yearly financial results. The document length is about 2641 characters, which is relatively short and focused on a specific capital/financial update. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2023-07-31 Chinese
北京诺禾致源科技股份有限公司关于全资子公司入选国家级专精特新“小巨人”企业的自愿性披露公告
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure announcement by Beijing Nuohe Zhiyuan Technology Co., Ltd. regarding its wholly-owned subsidiary being recognized as a national-level specialized and innovative "Little Giant" enterprise. It contains no financial statements, no regulatory form references, no voting results, no management changes, no earnings data, and no detailed financial or strategic presentations. The document is an official company announcement about a recognition event, which does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement informing the market about a corporate development. Given the content and length (890 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-07-20 Chinese
北京诺禾致源科技股份有限公司关于公司核心技术人员变更的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding changes in the company's core technical personnel. It details the adjustment of responsibilities and recognition of certain individuals as core technical staff, along with assurances about the impact on the company's operations and technology. There is no financial data, no mention of financial results, no regulatory filings about shareholding or capital changes, no legal proceedings, no meeting materials, and no report publication. The content focuses on management-level personnel changes related to technical staff, which falls under management or board information. Given the nature of the announcement about personnel changes at a senior technical level, the most appropriate classification is 'Board/Management Information' (MANG). The document length is 2391 characters, which is consistent with an announcement rather than a full report. Confidence is high due to clear content about personnel changes and no financial or regulatory report content.
2023-07-14 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.